Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2015 (2015), Article ID 910984, 5 pages
http://dx.doi.org/10.1155/2015/910984
Case Report

A Rare Presentation of Primary Hyperparathyroidism with Concurrent Aldosterone-Producing Adrenal Carcinoma

1Endocrinology Department, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, IMSS, Cuauhtémoc 330, Colonia Doctores, 06720 Mexico City, DF, Mexico
2Experimental Endocrinology Investigation Unit, Hospital de Especialidades, Centro Médico Nacional Siglo XXI, IMSS, Cuauhtémoc 330, Colonia Doctores, 06720 Mexico City, DF, Mexico

Received 2 March 2015; Revised 5 June 2015; Accepted 9 June 2015

Academic Editor: Carlo Capella

Copyright © 2015 Mario Molina-Ayala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. V. Thakker, “Multiple endocrine neoplasia type 1 (MEN1),” Best Practice and Research: Clinical Endocrinology and Metabolism, vol. 24, no. 3, pp. 355–370, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Waldmann, D. K. Bartsch, P. H. Kann, V. Fendrich, M. Rothmund, and P. Langer, “Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening,” Langenbeck's Archives of Surgery, vol. 392, no. 4, pp. 437–443, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. T. M. Seccia, A. Fassina, G. G. Nussdorfer, A. C. Pessina, and G. P. Rossi, “Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course,” Endocrine-Related Cancer, vol. 12, no. 1, pp. 149–159, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. L. M. Weiss, “Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors,” The American Journal of Surgical Pathology, vol. 8, no. 3, pp. 163–169, 1984. View at Publisher · View at Google Scholar · View at Scopus
  5. S. K. Agarwal, “Multiple endocrine neoplasia type 1,” Frontiers of Hormone Research, vol. 41, pp. 1–15, 2013. View at Publisher · View at Google Scholar
  6. W. S. Rubinstein, “Endocrine cancer predisposition syndromes: hereditary paraganglioma, multiple endocrine neoplasia type 1, multiple endocrine neoplasia type 2, and hereditary thyroid cancer,” Hematology/Oncology Clinics of North America, vol. 24, no. 5, pp. 907–937, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. V. Thakker, “Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4),” Molecular and Cellular Endocrinology, vol. 386, no. 1-2, pp. 2–15, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Langer, K. Cupisti, D. K. Bartsch et al., “Adrenal involvement in multiple endocrine neoplasia type 1,” World Journal of Surgery, vol. 26, no. 8, pp. 891–896, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. G. M. Hedbäck and A. S. Odén, “Cardiovascular disease, hypertension and renal function in primary hyperparathyroidism,” Journal of Internal Medicine, vol. 251, no. 6, pp. 476–483, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Rosenberg, M. Pines, and S. Hurwitz, “Response of adrenal cells to parathyroid hormone stimulation,” Journal of Endocrinology, vol. 112, no. 3, pp. 431–437, 1987. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Tomaschitz, E. Ritz, B. Pieske et al., “Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease,” Cardiovascular Research, vol. 94, no. 1, pp. 10–19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. V. S. Chhokar, Y. Sun, S. K. Bhattacharya et al., “Hyperparathyroidism and the calcium paradox of aldosteronism,” Circulation, vol. 111, no. 7, pp. 871–878, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. G. P. Rossi, F. Ragazzo, T. M. Seccia et al., “Hyperparathyroidism can be useful in the identification of primary aldosteronism due to aldosterone-producing adenoma,” Hypertension, vol. 60, no. 2, pp. 431–436, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. Brown, J. S. Williams, J. M. Luther et al., “Human interventions to characterize novel relationships between the renin-angiotensin-aldosterone system and parathyroid hormone,” Hypertension, vol. 63, no. 2, pp. 273–280, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Maniero, A. Fassina, V. Guzzardo et al., “Primary hyperparathyroidism with concurrent primary aldosteronism,” Hypertension, vol. 58, no. 3, pp. 341–346, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. J. P. Forman, J. S. Williams, and N. D. L. Fisher, “Plasma 25-hydroxyvitamin D and regulation of the renin-angiotensin system in humans,” Hypertension, vol. 55, no. 5, pp. 1283–1288, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Vaidya, J. M. Brown, and J. S. Williams, “The renin–angiotensin–aldosterone system and calcium-regulatory hormones,” Journal of Human Hypertension, 2015. View at Publisher · View at Google Scholar
  18. M. Honda, T. Tsukada, T. Horiuchi et al., “Primary hyperparathyroidism associatiated with aldosterone-producing adrenocortical adenoma and breast cancer: relation to MEN1 gene,” Internal Medicine, vol. 43, no. 4, pp. 310–314, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. L. Kim, Y. W. Jang, J. T. Kim et al., “A rare case of primary hyperparathyroidism associated with primary aldosteronism, hürthle cell thyroid cancer and meningioma,” Journal of Korean Medical Science, vol. 27, no. 5, pp. 560–564, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. S. H. Golden, K. A. Robinson, I. Saldanha, B. Anton, and P. W. Ladenson, “Clinical review: prevalence and incidence of endocrine and metabolic disorders in the united states: a comprehensive review,” The Journal of Clinical Endocrinology & Metabolism, vol. 94, no. 6, pp. 1853–1878, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. P. Fay, A. Elfiky, G. H. Telo et al., “Adrenocortical carcinoma: the management of metastatic disease,” Critical Reviews in Oncology/Hematology, vol. 92, no. 2, pp. 123–132, 2014. View at Publisher · View at Google Scholar
  22. A. Ganguly, “Primary aldosteronism,” The New England Journal of Medicine, vol. 339, no. 25, pp. 1828–1834, 1998. View at Publisher · View at Google Scholar · View at Scopus